Greyledge Technologies
Greyledge Technologies specializes in autologous cell therapeutics, offering customizable PRP and BMC preparations for a wide range of medical applications, including orthopedics, dermatology, and wound care.
Services
Greyledge Technologies specializes in autologous cell therapeutics, offering Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC) preparations. These services are designed to be fully customizable to meet individual patient needs. Greyledge supports a variety of medical applications including orthopedics, dermatology, cosmetic surgery, hair restoration, sexual dysfunction, dental and oral surgery, wound care, peripheral vascular disease, cardiac surgery, and neurology. They provide data collection and technician support to improve patient outcomes.
Products
Greyledge Technologies offers state-of-the-art biologic products including PRP and BMC preparations. These products are used for a wide range of applications such as orthopedic injuries, cosmetic procedures, hair restoration, and wound care. PRP stimulates the body's natural healing processes and reduces inflammation, while BMC contains stem cells that can differentiate into various types of cells to aid tissue restoration. The company uses data analytics to advance their autologous biologic treatments.
Technology Platform
Greyledge Technologies has developed a technology platform that allows physicians to incorporate autologous PRP and BMC preparations into their practices. This platform supports manual, laboratory-based methods for processing autologous blood and bone marrow tissues. It also includes data collection and physician-extending technicians to track patient-reported outcomes and enhance treatment results.
Medical Applications
Greyledge Technologies supports a wide range of medical fields through its autologous cell therapy products. These include orthopedics for ligament and tendon injuries, dermatology and cosmetic surgery for skin treatments, hair restoration for combating hair loss, sexual dysfunction treatments, dental and oral surgery for tissue repair, wound care for faster recovery, peripheral vascular disease, cardiac surgery with non-invasive alternatives, and neurology for nerve repair and regeneration.
Expansion and Funding
Greyledge Technologies has expanded its operations to multiple states including Texas, Michigan, Colorado, Ohio, Arizona, and Florida. In 2021, the company completed a seed capital raise of $2.5 million, enabling further development and deployment of its autologous cell therapy products and services.